# Combination Chemotherapy and Bevacizumab Before Surgery and Radiolabeled Monoclonal Antibody Therapy in Treating Liver Metastases in Patients With Metastatic Colorectal Cancer

> **NCT01320683** · PHASE2 · TERMINATED · sponsor: **City of Hope Medical Center** · enrollment: 1 (actual)

## Conditions studied

- Liver Metastases
- Recurrent Colon Cancer
- Recurrent Rectal Cancer
- Stage IVA Colon Cancer
- Stage IVA Rectal Cancer
- Stage IVB Colon Cancer
- Stage IVB Rectal Cancer

## Interventions

- **DRUG:** oxaliplatin
- **DRUG:** leucovorin calcium
- **DRUG:** fluorouracil
- **BIOLOGICAL:** bevacizumab
- **RADIATION:** yttrium Y 90 DOTA anti-CEA monoclonal antibody M5A
- **OTHER:** laboratory biomarker analysis
- **OTHER:** pharmacological study
- **DRUG:** irinotecan hydrochloride

## Key facts

- **NCT ID:** NCT01320683
- **Lead sponsor:** City of Hope Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-03
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Slow accrual.
- **Last updated:** 2016-07-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01320683

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01320683, "Combination Chemotherapy and Bevacizumab Before Surgery and Radiolabeled Monoclonal Antibody Therapy in Treating Liver Metastases in Patients With Metastatic Colorectal Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01320683. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*